Seeing Is Believing
Currently out of the existing stock ratings of Jason Mccarthy, 218 are a BUY (84.82%), 36 are a HOLD (14.01%), 3 are a SELL (1.17%).
Analyst Jason Mccarthy, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 45.25% that have a potential upside of 60.98% achieved within 289 days.
Jason Mccarthy’s has documented 495 price targets and ratings displayed on 84 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CODX, Co-Diagnostics at 23-Jan-2026.
Analyst best performing recommendations are on CODX (CO-DIAGNOSTICS).
The best stock recommendation documented was for CAPR (CAPRICOR THERAPEUTICS) at 9/17/2024. The price target of $12 was fulfilled within 13 days with a profit of $6.92 (136.22%) receiving and performance score of 104.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Apr-2025
$19
$13.74 (261.22%)
$21
3 months 13 days ago
(12-Nov-2025)
0/2 (0%)
$14.06 (284.62%)
Buy Since 16-Oct-2017
$20
$14.74 (280.23%)
$20
4 months 12 days ago
(13-Oct-2025)
0/10 (0%)
$14.59 (269.69%)
Buy Since 02-Jun-2025
$20
$14.74 (280.23%)
$19
6 months 10 days ago
(15-Aug-2025)
0/2 (0%)
$12.87 (180.50%)
Buy Since 30-May-2024
$20
$14.74 (280.23%)
$21
9 months 9 days ago
(16-May-2025)
0/2 (0%)
$13.9 (227.87%)
Buy Since 19-Feb-2025
$15
$9.74 (185.17%)
$15
11 months 1 days ago
(24-Mar-2025)
0/2 (0%)
$9.88 (192.97%)
Which stock is Jason Mccarthy is most bullish on?
Which stock is Jason Mccarthy is most reserved on?
What Year was the first public recommendation made by Jason Mccarthy?